Indoco Remedies Ltd
NSE:INDOCO
Indoco Remedies Ltd
Pre-Tax Income
Indoco Remedies Ltd
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Indoco Remedies Ltd
NSE:INDOCO
|
Pre-Tax Income
₹1.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Pre-Tax Income
₹72.8B
|
CAGR 3-Years
26%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Pre-Tax Income
₹65.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
23%
|
CAGR 10-Years
15%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Pre-Tax Income
₹133.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
6%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Pre-Tax Income
₹26.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
29%
|
CAGR 10-Years
9%
|
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Pre-Tax Income
₹24B
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Indoco Remedies Ltd
Glance View
Indoco Remedies Ltd. engages in manufacturing and marketing of Formulations (Finished Dosage Forms) and active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-01-07. The firm is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The firm's geographical segments include India and Outside India. The firm has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.
See Also
What is Indoco Remedies Ltd's Pre-Tax Income?
Pre-Tax Income
1.4B
INR
Based on the financial report for Mar 31, 2024, Indoco Remedies Ltd's Pre-Tax Income amounts to 1.4B INR.
What is Indoco Remedies Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 3Y
1%
Over the last year, the Pre-Tax Income growth was -30%. The average annual Pre-Tax Income growth rates for Indoco Remedies Ltd have been 1% over the past three years .
You don't have any saved screeners yet